Sopherion sopherion.com


Public lists: Pharma Startups (4732)

Sopherion is a therapeutics platform company initially focused on cancer.

Sopherion is a therapeutics platform company initially focused on cancer.

Company (Alive / Active)

Phone: 609-986-2020

Fax: 609-986-2059

104 Carnegie Center
Suite 200
Princeton, 08540
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Sopherion $129.3M Feb 17, 2009
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Sopherion Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Canaan PartnersVenture CapitalMenlo Park, California, United StatesSeries C, Series B
GE CapitalDiversified Financial ServicesNew York, New York, United StatesSeries A
Connecticut InnovationsVenture CapitalRocky Hill, Connecticut, United StatesSeries A
Devon Park BioventuresVenture CapitalChesterbrook, Pennsylvania, United StatesSeries C
Commerce Health VenturesVenture CapitalRadnor, Pennsylvania, United StatesSeries B
See all 16 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Non-pegylated liposomal doxorubicin triple combination therapy Sep 10, 2010 Sep 27, 2011 Patent
Non-pegylated liposomal doxorubicin combinations for the treatment of triple negative breast cancer Sep 05, 2013 Application